Literature DB >> 2170687

The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.

B Gloss1, H U Bernard.   

Abstract

The E6/E7 promoter of all genital human papillomaviruses is responsible for expression of the viral transforming genes. Centered 60 bp upstream of the transcription start, it contains a 20-bp segment with partially overlapping binding sites for the viral E2 proteins and for a cellular factor that was identified by footprint experiments. Bandshifts, bandshift competitions, and footprints revealed that protein complexes between nuclear extracts and these sequences have binding properties indistinguishable from those of the Sp1 factor that binds the simian virus 40 early promoter GC motif. Reactions of these complexes with anti-Sp1 antiserum were analyzed by superbandshifts and precipitation with protein A, and the results confirmed the identity of this transcription factor as Sp1. Sp1 binds in simian virus 40 and different human papillomavirus promoters the consensus sequence 5'-NGGNGN-3'. RNase protection analysis of in vitro or in vivo transcriptions with wild-type and mutant test vectors shows that the E6/E7 promoter of human papillomavirus type 16 is functionally dependent on the Sp1 distal promoter element. In all genital papillomaviruses, the Sp1 hexamer is invariably spaced by a single nucleotide from the distal E2 element, suggesting some precise interaction between Sp1 and E2 proteins. Published experimental evidence documents negative regulation of the E6/E7 promoter by E2 proteins through the proximal E2 element, whereas only minor quantitative differences in E6/E7 promoter function after cotransfection with E2 expression vectors were observed in this study. A detailed study of the interactions of Sp1 and E2 proteins with one another and with the corresponding three binding sites may reveal a complex modulation of this promoter.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170687      PMCID: PMC248610          DOI: 10.1128/JVI.64.11.5577-5584.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts.

Authors:  G Westin; T Gerster; M M Müller; G Schaffner; W Schaffner
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

2.  Human CCAAT-binding proteins have heterologous subunits.

Authors:  L A Chodosh; A S Baldwin; R W Carthew; P A Sharp
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

3.  Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products.

Authors:  S T Cole; O Danos
Journal:  J Mol Biol       Date:  1987-02-20       Impact factor: 5.469

4.  The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.

Authors:  B A Bernard; C Bailly; M C Lenoir; M Darmon; F Thierry; M Yaniv
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Oltersdorf; E Schwarz; L Gissmann
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

6.  A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs.

Authors:  C Santoro; N Mermod; P C Andrews; R Tjian
Journal:  Nature       Date:  1988-07-21       Impact factor: 49.962

7.  Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues.

Authors:  C C Baker; P M Howley
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

8.  The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.

Authors:  F Thierry; M Yaniv
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

9.  The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.

Authors:  B Gloss; H U Bernard; K Seedorf; G Klock
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

10.  Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.

Authors:  T P Cripe; T H Haugen; J P Turk; F Tabatabai; P G Schmid; M Dürst; L Gissmann; A Roman; L P Turek
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

View more
  48 in total

1.  Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes.

Authors:  F Thierry; G Spyrou; M Yaniv; P Howley
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.

Authors:  H D Royer; M P Freyaldenhoven; I Napierski; D D Spitkovsky; T Bauknecht; N Dathan
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106.

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Robert D Burk
Journal:  J Gen Virol       Date:  2007-11       Impact factor: 3.891

4.  Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.

Authors:  M A Ozbun; C Meyers
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes.

Authors:  W Zhao; L T Chow; T R Broker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  The integration of HPV-18 DNA in cervical carcinoma.

Authors:  S A Corden; L J Sant-Cassia; A J Easton; A G Morris
Journal:  Mol Pathol       Date:  1999-10

7.  Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements.

Authors:  C M Sanders; N J Maitland
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

8.  Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

9.  The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18.

Authors:  M Remm; R Brain; J R Jenkins
Journal:  Nucleic Acids Res       Date:  1992-11-25       Impact factor: 16.971

10.  Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs).

Authors:  Zigui Chen; Koenraad van Doorslaer; Rob DeSalle; Charles E Wood; Jay R Kaplan; Janice D Wagner; Robert D Burk
Journal:  Virology       Date:  2009-08-28       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.